Mesa Laboratories Pre-Tax Profit Margin 2011-2025 | MLAB
Mesa Laboratories pre-tax profit margin from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Mesa Laboratories Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.25B | $0.01B | 2.85% |
| 2025-06-30 | $0.24B | $0.01B | 3.70% |
| 2025-03-31 | $0.24B | $0.01B | 2.49% |
| 2024-12-31 | $0.24B | $-0.27B | -113.03% |
| 2024-09-30 | $0.23B | $-0.27B | -116.23% |
| 2024-06-30 | $0.22B | $-0.27B | -121.08% |
| 2024-03-31 | $0.22B | $-0.28B | -127.31% |
| 2023-12-31 | $0.21B | 0 | 0.00% |
| 2023-09-30 | $0.21B | 0 | 0.00% |
| 2023-06-30 | $0.22B | $0.00B | 1.82% |
| 2023-03-31 | $0.22B | 0 | 0.00% |
| 2022-12-31 | $0.22B | 0 | 0.00% |
| 2022-09-30 | $0.22B | $0.00B | -1.79% |
| 2022-06-30 | $0.20B | $0.00B | -1.00% |
| 2022-03-31 | $0.19B | $0.00B | 2.16% |
| 2021-12-31 | $0.16B | $0.01B | 5.49% |
| 2021-09-30 | $0.14B | $0.01B | 3.50% |
| 2021-06-30 | $0.14B | $0.00B | 1.44% |
| 2021-03-31 | $0.13B | $0.00B | 1.49% |
| 2020-12-31 | $0.13B | $0.00B | -2.31% |
| 2020-09-30 | $0.13B | $0.00B | -1.56% |
| 2020-06-30 | $0.12B | 0 | 0.00% |
| 2020-03-31 | $0.12B | $0.00B | 3.39% |
| 2019-12-31 | $0.11B | $0.01B | 5.45% |
| 2019-09-30 | $0.11B | $0.01B | 11.43% |
| 2019-06-30 | $0.10B | $0.01B | 8.65% |
| 2019-03-31 | $0.10B | $0.01B | 7.77% |
| 2018-12-31 | $0.10B | $0.01B | 11.54% |
| 2018-09-30 | $0.10B | $0.00B | 0.00% |
| 2018-06-30 | $0.10B | $0.00B | 2.02% |
| 2018-03-31 | $0.10B | $0.00B | -1.03% |
| 2017-12-31 | $0.09B | $0.00B | -2.13% |
| 2017-09-30 | $0.09B | $0.01B | 13.83% |
| 2017-06-30 | $0.10B | $0.01B | 13.68% |
| 2017-03-31 | $0.09B | $0.01B | 15.05% |
| 2016-12-31 | $0.09B | $0.02B | 15.96% |
| 2016-09-30 | $0.09B | $0.01B | 15.56% |
| 2016-06-30 | $0.09B | $0.01B | 15.91% |
| 2016-03-31 | $0.09B | $0.02B | 18.82% |
| 2015-12-31 | $0.08B | $0.01B | 17.72% |
| 2015-09-30 | $0.08B | $0.02B | 19.48% |
| 2015-06-30 | $0.07B | $0.02B | 22.97% |
| 2015-03-31 | $0.07B | $0.02B | 22.22% |
| 2014-12-31 | $0.07B | $0.02B | 23.19% |
| 2014-09-30 | $0.06B | $0.02B | 23.44% |
| 2014-06-30 | $0.06B | $0.01B | 22.41% |
| 2014-03-31 | $0.05B | $0.01B | 24.53% |
| 2013-12-31 | $0.05B | $0.01B | 26.00% |
| 2013-09-30 | $0.05B | $0.01B | 25.00% |
| 2013-06-30 | $0.05B | $0.01B | 25.53% |
| 2013-03-31 | $0.05B | $0.01B | 25.53% |
| 2012-12-31 | $0.05B | $0.01B | 24.44% |
| 2012-09-30 | $0.04B | $0.01B | 27.27% |
| 2012-06-30 | $0.04B | $0.01B | 28.57% |
| 2012-03-31 | $0.04B | $0.01B | 30.00% |
| 2011-12-31 | $0.04B | $0.01B | 30.00% |
| 2011-09-30 | $0.04B | $0.01B | 28.95% |
| 2011-06-30 | $0.04B | $0.01B | 27.78% |
| 2011-03-31 | $0.03B | $0.01B | 26.47% |
| 2010-12-31 | $0.03B | $0.01B | 27.59% |
| 2010-09-30 | $0.03B | $0.01B | 30.77% |
| 2010-06-30 | $0.02B | $0.01B | 34.78% |
| 2010-03-31 | $0.02B | $0.01B | 38.10% |
| 2009-12-31 | $0.02B | $0.01B | 40.00% |
| 2009-09-30 | $0.02B | $0.01B | 40.00% |
| 2009-06-30 | $0.02B | $0.01B | 38.10% |
| 2009-03-31 | $0.02B | $0.01B | 38.10% |
| 2008-12-31 | $0.02B | $0.01B | 36.36% |
| 2008-09-30 | $0.02B | $0.01B | 36.36% |
| 2008-06-30 | $0.02B | $0.01B | 38.10% |
| 2008-03-31 | $0.02B | $0.01B | 40.00% |
| 2007-12-31 | $0.02B | $0.01B | 42.11% |
| 2007-09-30 | $0.02B | $0.01B | 38.89% |
| 2007-06-30 | $0.02B | $0.01B | 35.29% |
| 2007-03-31 | $0.02B | $0.01B | 29.41% |
| 2006-12-31 | $0.02B | $0.00B | 26.67% |
| 2006-09-30 | $0.01B | $0.00B | 28.57% |
| 2006-06-30 | $0.01B | $0.00B | 30.77% |
| 2006-03-31 | $0.01B | $0.00B | 36.36% |
| 2005-12-31 | $0.01B | $0.00B | 36.36% |
| 2005-09-30 | $0.01B | $0.00B | 36.36% |
| 2005-06-30 | $0.01B | $0.00B | 40.00% |
| 2005-03-31 | $0.01B | $0.00B | 36.36% |
| 2004-12-31 | $0.01B | $0.00B | 40.00% |
| 2004-09-30 | $0.01B | $0.00B | 44.44% |
| 2004-06-30 | $0.01B | $0.00B | 44.44% |
| 2004-03-31 | $0.01B | $0.00B | 50.00% |
| 2003-12-31 | $0.01B | $0.00B | 50.00% |
| 2003-09-30 | $0.01B | $0.00B | 50.00% |
| 2003-06-30 | $0.01B | $0.00B | 50.00% |
| 2003-03-31 | $0.01B | $0.00B | 50.00% |
| 2002-12-31 | $0.01B | $0.00B | 50.00% |
| 2002-09-30 | $0.01B | $0.00B | 50.00% |
| 2002-06-30 | $0.01B | $0.00B | 44.44% |
| 2002-03-31 | $0.01B | $0.00B | 44.44% |
| 2001-12-31 | $0.01B | $0.01B | 55.56% |
| 2001-09-30 | $0.01B | $0.01B | 55.56% |
| 2001-06-30 | $0.01B | $0.01B | 62.50% |
| 2001-03-31 | $0.01B | $0.01B | 62.50% |
| 2000-12-31 | $0.01B | $0.00B | 44.44% |
| 2000-09-30 | $0.01B | $0.00B | 44.44% |
| 2000-06-30 | $0.01B | $0.00B | 44.44% |
| 2000-03-31 | $0.01B | $0.00B | 44.44% |
| 1999-12-31 | $0.01B | $0.01B | 62.50% |
| 1999-09-30 | $0.01B | $0.01B | 75.00% |
| 1999-06-30 | $0.01B | $0.01B | 87.50% |
| 1999-03-31 | $0.01B | $0.01B | 100.00% |
| 1998-12-31 | $0.01B | $0.01B | 100.00% |
| 1998-09-30 | $0.01B | $0.01B | 100.00% |
| 1998-06-30 | $0.01B | $0.01B | 100.00% |
| 1998-03-31 | $0.01B | $0.01B | 100.00% |
| 1997-12-31 | $0.01B | $0.01B | 100.00% |
| 1997-09-30 | $0.01B | $0.01B | 100.00% |
| 1997-06-30 | $0.01B | $0.01B | 87.50% |
| 1997-03-31 | $0.01B | $0.01B | 87.50% |
| 1996-12-31 | $0.01B | $0.01B | 87.50% |
| 1996-09-30 | $0.01B | $0.01B | 75.00% |
| 1996-06-30 | $0.01B | $0.01B | 87.50% |
| 1996-03-31 | $0.01B | $0.01B | 62.50% |
| 1995-12-31 | $0.01B | $0.00B | 50.00% |
| 1995-09-30 | $0.01B | $0.00B | 50.00% |
| 1995-06-30 | $0.01B | $0.00B | 25.00% |
| 1995-03-31 | $0.01B | $0.00B | 28.57% |
| 1994-12-31 | $0.01B | $0.00B | 14.29% |
| 1994-09-30 | $0.01B | 0 | 0.00% |
| 1994-06-30 | $0.01B | 0 | 0.00% |
| 1994-03-31 | $0.01B | 0 | 0.00% |
| 1993-12-31 | $0.01B | $0.00B | 20.00% |
| 1993-09-30 | $0.00B | $0.00B | 25.00% |
| 1993-06-30 | $0.00B | $0.00B | 25.00% |
| 1993-03-31 | $0.00B | $0.00B | 50.00% |
| 1992-12-31 | $0.00B | $0.00B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.437B | $0.241B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.585B | 25.62 |
| Intuitive Surgical (ISRG) | United States | $199.284B | 77.97 |
| IDEXX Laboratories (IDXX) | United States | $56.042B | 55.66 |
| Edwards Lifesciences (EW) | United States | $48.699B | 32.65 |
| Alcon (ALC) | Switzerland | $39.563B | 26.74 |
| IQVIA Holdings (IQV) | United States | $37.963B | 21.17 |
| Mettler-Toledo (MTD) | United States | $28.719B | 33.60 |
| DexCom (DXCM) | United States | $26.350B | 36.32 |
| STERIS (STE) | Ireland | $25.404B | 26.23 |
| Waters (WAT) | United States | $23.565B | 31.17 |
| Hologic (HOLX) | United States | $16.680B | 17.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.919B | 0.00 |
| Penumbra (PEN) | United States | $11.869B | 83.49 |
| Globus Medical (GMED) | United States | $11.754B | 24.67 |
| Masimo (MASI) | United States | $7.508B | 24.06 |
| Glaukos (GKOS) | United States | $6.244B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.917B | 18.80 |
| Teleflex (TFX) | United States | $5.767B | 9.19 |
| TransMedics (TMDX) | United States | $4.484B | 53.12 |
| LivaNova (LIVN) | United Kingdom | $3.498B | 18.90 |
| Veracyte (VCYT) | United States | $3.425B | 39.04 |
| Alphatec Holdings (ATEC) | United States | $3.105B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.521B | 11.83 |
| Elekta AB (EKTAY) | Sweden | $2.116B | 19.79 |
| Artivion (AORT) | United States | $2.094B | 96.11 |
| PROCEPT BioRobotics (PRCT) | United States | $1.995B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.838B | 16.05 |
| UFP Technologies (UFPT) | United States | $1.649B | 21.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.454B | 0.00 |
| AxoGen (AXGN) | United States | $1.384B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.237B | 58.91 |
| Integra LifeSciences Holdings (IART) | United States | $1.064B | 5.76 |
| OPKO Health (OPK) | United States | $1.052B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.962B | 0.00 |
| SiBone (SIBN) | United States | $0.815B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.716B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.643B | 37.36 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.627B | 0.00 |
| NeuroPace (NPCE) | United States | $0.559B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.549B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.542B | 10.81 |
| RxSight (RXST) | United States | $0.518B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.471B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.447B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.429B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.373B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.350B | 58.35 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.275B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.224B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.182B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.161B | 0.00 |
| Solana (HSDT) | United States | $0.157B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Accuray (ARAY) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.104B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| DarioHealth (DRIO) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.051B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |